Yungjin Pharm Co Ltd (003520) — Cash Flow-to-Debt Ratio
Yungjin Pharm Co Ltd (003520) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of ₩7.00 Billion could theoretically repay 0% of its total liabilities (₩156.23 Billion) in one year. See Yungjin Pharm Co Ltd (003520) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Yungjin Pharm Co Ltd Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Yungjin Pharm Co Ltd across 12 annual periods. Also explore Yungjin Pharm Co Ltd (003520) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Yungjin Pharm Co Ltd (2013–2024)
Year-by-year debt coverage analysis for Yungjin Pharm Co Ltd. For market capitalisation and broader financial context, see 003520 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.15x | ₩21.74 Billion | ₩144.45 Billion | ▲ +301.6% |
| 2023 | -0.07x | ₩-10.22 Billion | ₩136.97 Billion | ▲ +27.2% |
| 2022 | -0.10x | ₩-11.61 Billion | ₩113.21 Billion | ▼ -209.3% |
| 2021 | 0.09x | ₩8.37 Billion | ₩89.21 Billion | ▼ -52.3% |
| 2020 | 0.20x | ₩14.50 Billion | ₩73.67 Billion | ▲ +79.6% |
| 2019 | 0.11x | ₩9.28 Billion | ₩84.69 Billion | ▲ +626.9% |
| 2018 | 0.02x | ₩1.27 Billion | ₩84.51 Billion | ▼ -59.7% |
| 2017 | 0.04x | ₩3.15 Billion | ₩84.20 Billion | ▲ +12.1% |
| 2016 | 0.03x | ₩3.11 Billion | ₩93.19 Billion | ▼ -64.6% |
| 2015 | 0.09x | ₩8.80 Billion | ₩93.27 Billion | ▲ +18.7% |
| 2014 | 0.08x | ₩6.22 Billion | ₩78.18 Billion | ▼ -10.7% |
| 2013 | 0.09x | ₩5.95 Billion | ₩66.89 Billion | — |